© Copyright Nostre Net
Market Insights
The non-invasive nature of optical coherence tomography (OCT) and its ability to generate a false-color depiction of tissue structure has made the global market for OCT highly lucrative. OCT is comparable to ultrasound imaging, with the principal difference that the technology uses light instead of sound. Research & development of the technology has led to efficient, fast and accurate OCT devices which have branched out from ophthalmology to include medical applications in dermatology, and cardiology among others, thus facilitating growth. Market Research Future's report on OCT market predicts an estimated evaluation of USD 1.48 billion by 2023 and an impressive CAGR of 8.9% during the forecast period of 2017 to 2023.
Prevalence of eye diseases and the rising occurrence of cardiac conditions have motivated market growth. Rising demand for OCT has led to R&D for technological advancements which in turn is expected to increase market growth further. Presently, although there are many applications for OCT devices, they are primarily used in ophthalmology, this indicates unrealized potential yet to be explored which will likely push demand for this technology in the coming years.
High costs associated with portable optical coherence tomography may hamper growth. However, increasing use in various applications, supportive government regulations and favorable reimbursements are likely to mitigate this challenge to a great extent.
Market Segmentation
The optical coherence tomography market has been segmented by technology, application, type of devices and region.
By technology, the market has been segmented into spectral-domain OCT (SD-OCT), swept-source OCT, and others. The SD-OCT segment is predicted to dominate with approximately 60% share of the total market during the forecast period. Meanwhile, swept-source OCT is the fastest growing segmented and is expected to grow at CAGR of 9.1% during the review period.
By application, the market has been segmented into cardiology, ophthalmology, dermatology, oncology, and others. Ophthalmology has the most significant segment with over 53% of the market share. However, dermatology is the fastest growing application segment and is expected to grow at a considerable 9.3% CAGR during the forecast period.
By type of devices, the market has been segmented into handheld OCT devices, tabletop OCT devices, catheter-based OCT devices, and others.
By region, the market has been segmented into the Americas, Europe, Asia Pacific and the Middle East and Africa.
Regional Analysis
The Americas hold the largest share with nearly 37% of the global market share. Increasing occurrence of diabetic retinopathy and other eye diseases is one of the key factors driving the growth of the market. Moreover, there is a strong presence of market leaders. MRFR as predicted that region will reach an evaluation of approximately USD 558.34 million by 2023.
Europe follows the Americas lead and is expected to maintain a strong second lead due to supportive government policies and research & development carried out by private players is the primary propeller for the growth of the OCT market over the forecast period. The region is expected to closely follow the growth pattern of the Americas.
The Asia-Pacific region, is predicted to be the fastest growing region with a CAGR of 9.4% during the forecast period. A massive patient population in the region with a rising incidence of eye diseases and diabetic retinopathy is expected to fuel rapid growth for the region. International market leaders are trying to enter this region, and this is likely to facilitate growth in the coming years further.
The Middle East & Africa are expected to experience limited growth. This is primarily due to the passive development in the African continent.
Key Players
Market leaders have been featured in the report to provide a comprehensive understanding of the competitive landscape. Prominent players included in the report are Imalux Corporation, Optovue, Michelson Diagnostics, Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo Corporation, KONINKLIJKE PHILIPS N.V, B. Braun Melsungen AG, Boston Scientific Corporation, OPTOPOL Technology S.A, Heidelberg Engineering GmbH, Topcon Corporation, NIDEK Co., Ltd, Novacam Technologies Inc, Thorlabs Inc., and Agfa Healthcare
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Synopsis
The Global Pediatric Vaccines Market is expected to register 10.6% CAGR during the forecast period (2017-2023) to prevent diseases, asserts Market Research Future (MRFR). Vaccines administered to children to prevent them from several infectious and non-infectious diseases are referred to as pediatric vaccines. They are either heat-killed or inactivated viruses which lose their pathogenicity. These inactivated antigens stimulate the immune system so that they can produce antibodies against the infected virus.
Potential and Pitfalls
Various pediatric vaccines available in the market are hepatitis B antibody, flu immunization, meningococcal immunization, pneumococcal immunization, rotavirus immunization, Hib antibody, polio antibody, and MMR immunization. With growing economic growth, rising awareness associated with the benefits of vaccination in prevention of diseases, and favorable reimbursement, the global market for pediatric vaccine is anticipated to flourish during the estimated period. The growing collaboration of local manufacturers with the major market players to deliver high-quality vaccines in the remote areas are further considered to foster the market growth in the coming years. Moreover, high prevalence of chronic diseases is one of the key factors boosting the global market. Infants are more prone to severe diseases, and therefore vaccination plays an important role in their prevention.
On the flip side, availability of biosimilars at low rates, limited access to health care services in under-developed and developing countries, and low healthcare spending are some of the major factors restraining the market growth. Moreover, low accessibility to remote areas, increasing cost of vaccines, and less medical coverage for pediatric vaccination are some of the other factors hindering the market growth.
Competitive Dashboard
The major players operating the global pediatric vaccines market are Zydus Cadila (India), S K Chemicals (South Korea), AstraZeneca (UK), Bio Med (India), Sanofi Pasteur SA (France), Bharat Biotech (India), Shenzhen Kangtai Biological Products (China), Sinovac Biotech (China), Pfizer Inc. (U.S.), Nuron (U.S.), CSL Limited (Australia), Merck & Co. Inc. (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S.), Dynavax Technologies (U.S.), LG Life Sciences (India), Kaketsuken (U.S.), Emergent BioSolutions Inc. (U.S.), Crucell (Netherlands), GlaxoSmithKline plc (U.K.), Grifols (Spain), Bharat Immunologicals and Biologicals (India), Lupin Pharmaceuticals, Inc. (India), Panacea Biotec (India), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Novartis AG (Switerzland), Astellas Pharma Inc. (Japan), Johnson & Johnson (U.S.), bioCSL Inc. (U.S.), Takeda Pharmaceutical (Japan), MedImmune LLC (U.S.), Indian Immunologicals (India), Baxter International (U.S.), Valeant Pharmaceuticals (U.S.) and others.
Global Pediatric Vaccines Market: Segmental Analysis
The global pediatric vaccines market has been segmented on the basis of technology, type, route of administration, disease indication, and region.
By mode of type, the global pediatric vaccines market is segmented into multivalent vaccines, monovalent vaccines, and others.
By mode of technology, the global pediatric vaccines market is segmented into conjugate vaccines, dendritic cells vaccines, pediatric mobility devices, recombinant vaccines, inactivated and subunit vaccines, live attenuated vaccines, synthetic vaccines, toxoid vaccines, and others. Among these, the conjugate vaccines segment is likely to dominate the market owing to the increasing prevalence of meningococcal and pneumococcal infections.
By mode of disease indication, the global pediatric vaccines market is segmented into hepatitis, meningococcal disease, MMR (measles, mumps, and rubella), rotavirus, polio, combination vaccines, varicella, pneumococcal disease, haemophilus influenza type B, influenza, DTP (diphtheria, tetanus, pertussis), and others.
By mode of route of administration, the global pediatric vaccines market is segmented into subcutaneous administration, intramuscular administration, oral administration, and others.
Regional Insights
Geographically, the pediatric vaccines market span across regions namely, Europe, America, the Middle East and Africa, and the Asia Pacific region.
Among all the regions, America is considered to hold the largest market share and is likely to maintain its dominance during the assessment period. The growth is mainly attributed to the increasing initiatives taken by the U.S. Department of Health and Human Services in order to minimize the occurrence rate of infectious diseases
Europe is presumed to register a significant growth rate owing to the superior government spending like the National Health Service for the deployment of medical and pharmaceutical industries.
Asia Pacific is estimated to expand at a rapid pace owing to the increasing healthcare sector in the leading regions such as India and China. The Middle East and African region are also likely to expand at a steady pace due to extensive research and development activities coupled with the development in the healthcare infrastructure in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Insights
Market Research Future (MRFR) has released a report on the global chronic kidney disease which projects a moderate CAGR of 5.2% during the assessment period of 2017 to 2023. Rising occurrences of chronic diseases and the severity of kidney disease has increased the demand for an effective treatment option for the disease. Causes of chronic diseases are often indicated by diabetes, polycystic kidney disease, and high blood pressure among others.
Increasing prevalence of kidney diseases and the increased number of biopsy procedures have resulted in high demand for new diagnostic and treatment options for such chronic diseases. The global chronic kidney disease market has become highly competitive with the increasing entry of new market players; this is expected to stimulate growth during the forecast period. Kidney disease symptoms are often negligible in the initial phases, and this type of disease is widely referred to as a "silent disease" as detection often happens when the diseases are progressed to a later stage. This has increased the need for appropriate diagnostic measures and is driving market growth.
Increasing R&D activities with regards to diagnostics and treatment are expected to offer market growth opportunities in the future. Moreover, developing economies offer a wider scope for growth during the forecast period and are expected to affect the market positively.
Market Segmentation
MRFR's report segments the global chronic kidney disease market on the basis of diagnosis, treatment, indication, and end-user. By diagnosis, the market is segmented into blood test, urine test, imaging test, and kidney biopsy. By treatment, the market is segmented into drugs, dialysis, and kidney transplant. Drugs are further sub-segmented to include ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.
By indication, the market is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, apol1 mediated kidney diseases and others. By end-user, The market is segmented into hospitals and clinics, diagnostic centers, and others. Globally, the market is divided into the Americas, Europe, Asia-Pacific & the Middle East and Africa.
Regional Analysis
The Americas and Europe are significant regional markets which have a similar growth pattern. The growth of medical devices, increasing awareness regarding kidney diseases and the rapid increase in occurrences of chronic diseases is expected to drive growth in these regions. Moreover, they display a robust demand for new treatment methods and options. Opportunities for these markets are being driven by the increasing emphasis on the development of new drugs. Supportive government legislature with regards to research & development and the availability of funds for research in these regions is expected to push the market in a forward direction.
Asia-Pacific is another important market due to its rapid growth. Prevalence of diseases such as diabetes and cardiovascular diseases are driving the demand for appropriate treatment options. The region has a rapidly improving healthcare sector which has improved infrastructure, and a wide pool of skilled healthcare professionals. Demand for advanced treatment technologies and other healthcare technology is expected to provide the market with opportunities for market expansion.
Key Players
MRFRs report includes the analysis of market players participating in the global chronic kidney diseases competitive landscape. Top market players include Hoffman-La Roche Ltd., Abbott, AstraZeneca Plc, Pfizer, Nova Biomedical, ARKRAY, OPTI Medical, and AbbVie to name a few.
Latest Industry News
Researchers of the Loyola Medicine and Loyola University, Chicago Stritch School of Medicine, have found that medical nutrition therapy is the most important effective way to slow the progression of kidney diseases and prevent failure of the organs.
Johnson & Johnson has recorded highly positive data from the phase III of its chronic kidney diseases study of the drug Invokana. The company plans to release details regarding findings at a scientific conference soon.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Synopsis:
Market Research Future (MRFR) has published a report stating that the global dietary supplements in teh age of personalized nutrition market is anticipated to expand moderately at a CAGR of 6.90% during the forecast period of 2017-2023. Increasing awareness regarding the necessity of nutrients in daily diet and rise in popularity of fitness programs are primarily propelling the expansion of the global dietary supplements in the age of personalized nutrition market. Increasing incorporation of technologically advanced research and manufacturing processes in the pharmaceutical and healthcare industry along with the high demand for personalized medication are also fueling the growth of the global dietary supplements in the age of personalized nutrition market. However, concerns regarding the side effects cause by these supplements are likely to act as restraining factors for the growth of the global dietary supplements in the age of personalized nutrition market during the forecast period.
Key Players:
The major players profiled by MRFR that are operating in the global dietary supplements in the age of personalized nutrition market are Nestlé Health Science, Danone Nutricia, Carlyle Group, Amway (Nutrilite), Archer Daniels Midland, Abbott Laboratories, Herbalife International, Amway, Danisco, Glanbia, Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Balchem Corporation, Natures Product Inc., Bactolac Pharmaceutical Inc. and others.
Regional Analysis:
The global dietary supplements in the age of personalized nutrition market has been geographically segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. Among these, the Americas command for the major share in the global dietary supplements in teh age of personalized nutrition market owing to the presence of leading manufacturers, high healthcare expenditure by the population of this region and utilization of advanced technology for the production of personalized drugs and supplements in this region. Increased research in the nutrition industry for the development of personalized dietary supplements by studying the DNA, dietary habits and other factors in an individual is majorly propelling the expansion of teh dietary supplements in the age of personalized nutrition market. Improving economic conditions, increasing geriatric population, government support for research and development in teh healthcare sector and rise in awareness regarding the health benefits of dietary supplements are boosting the dietary supplements in the age of personalized drugs market in the Asia Pacific region. Whereas, low penetration of proper healthcare services and lack of awareness among the population of the underdeveloped regions are leading to the slow growth of the dietary supplements in the age of personalized nutrition market in the Middle East and Africa market.
Market Segmentation:
The global dietary supplements in the age of personalized nutrition market has been segmented on the basis of product category, gender, application, dosage form and end user. Based on product category, the market has been segmented into vitamins, herbs & botanicals, sports supplements, dietary supplements ingredients, meal supplements, minerals and other. Based on application, the market has been segmented into lifestyle diseases, inherited diseases, genetic predispositions and others. Based on gender, the market has been segmented into female and male. The female segment has been sub-segmented into 55 + age group, 35-54 age group, 19-34 age group, and 0-18 age group. The male segment has also been sub-segmented into 55 + age group, 35-54 age group, 19-34 age group, and 0-18 age group. Based on dosage form, the market has been segmented into tablets, capsules, powder, liquids, soft gels and others. Based on end users, the market has been segmented into hospitals & clinics, home care, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global diabetic nephropathy market is expected to reach a mammoth valuation by exhibiting 5.2% CAGR from 2018 to 2023 (forecast period). This can be attributed to rising cases of obesity and diabetes. Immense demand for diagnostic and imaging tests such as kidney biopsy, blood test, urine test, CT scan, and MRI scans can fuel the market demand. According to the World Health Organization, patients with chronic diseases touched a high of 35 million globally.
Diabetic nephropathy, known as diabetic kidney disease (DKD), is a kidney malady frequently found in patients with type 1 and type 2 diabetes. High prevalence of diabetes globally has culminated in diabetes co-morbidities. It can cause nephropathy which would require dialysis or a transplant. The global diabetic nephropathy market report by Market Research Future (MRFR) provides a quantitative and qualitative analysis by listing out trends, factors, and restraints with ample figures and statistics to back up the evidence.
Technological advances in diagnostic imaging and emphasis on early diagnosis for prevention of diseases are other drivers of the market. The expansion of the healthcare sector and availability of these tests at reputed hospitals and clinics can lend credibility to the trend. Rising number of clinical trials conducted to test the success of drugs for inhibiting the progress of DKD can provide new growth avenues. Angiotensin converting enzyme inhibitors (ACEi) have been known to have moderate success in clinical trials with placebo treatment in reducing the risk of death in patients with diabetes.
But high costs of these imaging tests can pose a challenge to the market growth.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/5664
Competitive Outlook
Bayer AG, Siemens AG, AbbVie Inc., Eli Lilly and Company, Mitsubishi Tanabe Pharma Corporation, Reata Pharmaceuticals, Inc., Pfizer Inc., Abbott, Merck & Co., Inc., General Electric Company, Novartis AG, Sanofi, and others are some of the noteworthy players in the global diabetic nephropathy market. Increased investments in research and development and drug discovery pertaining to chronic kidney disorders are the main focus of these players.
Segmentation Analysis
The global diabetic nephropathy market is segmented by diagnosis, treatment, indication, and end-user.
By diagnosis, it is segmented into imaging tests, urine tests, blood tests, renal function testing, and kidney biopsy. By treatment, it is segmented into kidney dialysis, medications, and transplant. By indication, it is segmented into diabetes 1 and diabetes 2. By end-user, it is segmented into research institutes, hospitals & clinics, diagnostic centers, and others.
Regional Analysis
Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions covered in the diabetic nephropathy market report.
The Americas are pegged to lead the global market till 2023 due to emphasis on diagnostic tests, constant monitoring of insulin levels, and large prevalence of chronic kidney disease (CKD). According to the U.S. National Chronic Kidney Disease, nearly 39 million Americans have CKD as of 2019. Large awareness levels can drive the regional market demand. This is exemplified with the American Diabetes Association for creating programs among diabetics for diabetes management.
The European region is deemed to be driven by kidney diagnosis tests for the geriatric populace combined with demand for diagnostic services. Germany is touted to be one of the biggest regions due to investment in new technologies and favorable reimbursement policies. High awareness of diabetes and its negligence which can cause kidney disorders is likely to drive the regional diabetic nephropathy market.
On the other hand, the APAC region is the third biggest globally and will sustain its ranking till the end of the forecast period. High prevalence of diabetes in Thailand, China, Japan, and India combined with chances of DKD in the region due to low patient awareness levels can work favorably for the market. The large geriatric population in these countries can also count as a viable factor driving the global diabetic nephropathy market growth.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/diabetic-nephropathy-market-5664
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Highlights
An insightful report furnished by Market Research Future (MRFR) suggests that the Asia Pacific (APAC) Aesthetics Market is poised to grow at an approximate growth rate of 11.50% during the forecast period (2017-2023).
The importance of beauty and personal appearance currently is at an all-time high as compared to earlier times due to the development of social media proliferation, thus boosting the Asia Pacific Aesthetics Market. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The Asia Pacific Aesthetics Market is estimated to gain a strong assessment of USD 12,175.1 MN by the conclusion of 2025.
Prominent Companies
ZELTIQ Aesthetics Inc. (U.S.), Galderma S.A. (Switzerland), Alma Lasers (Israel), Lumenis (Israel), PhotoMedex, Inc. (U.S.), Cutera (U.S.), Johnson & Johnson Services, Inc. (U.S.), Solta Medical, Inc. (Canada), Syneron Medical Ltd. (U.S.), Mentor Worldwide LLC (U.S), Merz Pharma (Germany), Integra Lifesciences (U.S.), Cynosure Inc. (U.S.), ALLERGAN (Ireland), Sanofi (France), are some of the leading companies in the Asia Pacific aesthetics market.
Market Segmentation
The Asia Pacific aesthetics market has been segmented on the basis of procedures, products, application, and end-user.
The various procedures in the market are surgical aesthetic procedures and nonsurgical aesthetic procedures. The surgical aesthetic procedures are categorized into liposuction, breast augmentation, tummy tuck, eyelid surgery, breast lift, dermabrasion, and others. On the other hand, the nonsurgical aesthetic procedures are split into the segments of botulinum toxin, hyaluronic acid, hair removal, photorejuvenation (IPL), chemical peel, microdermabrasion, and others.
Product-wise, the market caters to laser and energy-based devices, skin tightening and body contouring devices, aesthetic implants, and others. The types of skin tightening and body contouring devices are liposuction devices, injectable aesthetics, cellulite reduction devices, cryolipolysis technology, anti-aging device, and others. The aesthetic implants are fragmented into dental implants, breast implants, buttock augmentation, transdermal implants, and others.
The various applications are facial & body contouring, facial & skin rejuvenation, breast enhancement, scar treatment, reconstructive surgery, tattoo removal, vaginal rejuvenation, and so on.
Depending on end-user, the market can be segmented based on hospitals & clinics, dermatology clinics, cosmetic centers, and others.
Detailed Regional Analysis
The regional scrutiny of the Asia Pacific Aesthetics Market consists of North America, Europe, Africa, and the Middle East. The North American region’s Asia Pacific Aesthetics Market is estimated to emerge as the principal regional market in the overall Americas region. The aesthetic industry growth in the North American region is the outcome of the speedy development in beauty treatments and various anti-aging cosmetic operations. The Mexican aesthetic devices market in the region has been bolstered by the mounting interest in cosmetic techniques, improving healthcare infrastructure, intensifying problem of skin illnesses, and the increasing number of accomplished board-certified cosmetic doctors. The regional market of Europe is promoted to be the next highest gainer in the worldwide market in the future, supported by the collective support given by the government and the great population of elderly patients who need improvement in physical form. The substantial healthcare expenditure is another development-inducing influence in the regional market. The APAC regional market is estimated to be driven due to the exploding patient population, swift innovations in technology, and the profusion of lucrative prospects for global companies in the region. The UAE aesthetic devices market in the Middle Eastern region is mounting at an encouraging rate, because of the rising surgeries counting facial fat grafting, breast enlargement, liposuction, and more. The need for innovative devices and tools to ensure safer and more effective procedures are projected to guide the Asia Pacific Aesthetics Market in the region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Scope
The Global Home Healthcare Market will grow at a CAGR of 11.6% during the forecast period 2020 to 2027. The market for home healthcare is set to reach USD 273.9 Billion by 2027. As per market analysts, the global market is anticipated to witness growth owing to the factors such as technological advances in healthcare and diagnosis equipment as well as government initiatives encouraging home healthcare. However, the market will face challenges and restraints due to concerns regarding patient safety and increasing healthcare costs during the forecast period 2020 to 2027.
Drivers and Restrains Impacting Home Healthcare Market
The rise of the global home healthcare market is can be attributed to factors, such as; adoption of advanced technology in healthcare and diagnosis equipment and introduction of initiatives by governments to encourage home healthcare solutions. On the contrary, the home healthcare market is anticipated to face challenges and restraints owing to rising about patient safety and high healthcare costs. However, the expansion of the geriatric population in can support the market rise in years to come.
Competitive Landscape of Home Healthcare Market
Some reputed companies that are functioning in the home healthcare market include Abbott (U.S.), Koninklijke Philips N.V. (The Netherlands), Fresenius SE & Co KGaA (Germany), F. Hoffmann-La Roche AG (Switzerland), GE Healthcare (U.S.), A&D Company (Japan), B. Braun Melsungen AG (Germany), McKesson Corporation (U.S.), Omron Corporation (Japan), Becton Dickinson Company (U.S.), LG Electronics (South Korea), Medtronic PLC (U.S.), Apple (U.S.), Kinnser Software (U.S.), and 3M (U.S.) and others. Eminent players are engaged in launching new products and entering partnerships in the global market and to expand their consumer base.
Segment Analysis of Home Healthcare Market
The home healthcare market segment study is based on product, software, and service.
By products, the segments of the home healthcare market study are screening, therapeutic and testing, and monitoring products. The segment of therapeutic and testing is sub-segmented into respiratory therapy equipment, dialysis equipment, insulin delivery devices, IV equipment, and wound care products among others. The segment of monitoring products is sub-segmented into event monitors, holter, sleep apnea monitors, pulse oximeters & heart rate monitors, blood pressure monitors, blood glucose monitors, and cholesterol monitoring devices among others.
By software, the home healthcare market study is segmented into hospice solutions, agency software, telehealth solution, and clinical management systems. The telehealth solution segment can rise at high growth pace over the years to come.
By services, the global home healthcare market is segmented into unskilled care services, skilled nursing services, personal home health care, rehabilitation therapy services, respiratory therapy services, infusion pregnancy care services, and therapy services. The expansion of the respiratory therapy services to support market.
Regional Assessment of Home Healthcare Market
The growing concerns regarding authenticity and safety of treatment are encouraging innovations that can influence the home healthcare market expansion in different regions across the globe. The market research report reveals that companies in the global home healthcare market can be supported by new revenue sources that are utilized by key market players and the surging investment over the forecast term. The regional analysis of the market is spread across Europe, North America, and Asia-Pacific among other. As per market study, the home healthcare market is set to experience a tremendous growth across software, product, service, and region segments. The home healthcare market in North America region covers the United States, and Mexico and Canada. Businesses present in this regional market are profiled for their strategies and are presented in detail in this market report. The home healthcare market in the European region covers Germany, Italy, France, and the United Kingdom. Further, the market research report offers details on the APAC region that spans across China, Japan, India, Australia, and others. The market active across other parts of the world, such as; Middle East, Brazil, and Africa, others in the home healthcare market are also studied.
The report offers vivid profiles on market players and study their current scenario in the market. History of companies coupled with their annual turnover, segmental share, profit margins, growth strategies, SWOT analysis, mergers and acquisitions (M&A) activities, new product launches, and R&D initiatives are discussed on a granular level.
The market report provides comprehensive analysis of the worldwide home healthcare market in segments that include service, product, region, and software. Analysts have also assessed the market's rise across several regional markets across different market’s segments on a country level. The research report of the home healthcare market highlights key segments that offers forecasts on the basis of primary and secondary data. The report on the global market of home healthcare presents key company profiles on organizations that are active across the several regions.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Insights
Stem cells have been acknowledged for their promising potential toward the development of various cutting-edge treatments for a number of diseases. As such, stem cell assays have a rapidly growing market. Stem cell assays are essentially the techniques used for analyzing living cells by various parameters which ultimately help determine the biochemical and cellular functioning of cells. This has immense promise in drug development activities. Market Research Future's study of the market in its latest report has found that the global stem cell assay market is on track to register a highly optimistic outlook at a CAGR of 19.80% during the review period from 2017 to 2023.
Stem cell assays are a promising part of the biotechnology field, which is growing at a rapid pace. The prevalence of chronic and several lifestyle diseases has compelled the growth of drug development activities in an effort to develop effective treatments. Diseases such as cancer and diabetes are soaring at high rates and the demand for better, efficient and more affordable treatments are driving the market toward growth. Healthcare expenditure across the globe is increasing, and advancement in biotechnology and other medical technologies is highly encouraging of market growth. Government support toward drug development for chronic diseases has increased stem cell assay market research.
The market is held back by stringent government policies associated with approval of drugs as well as the high procedural cost of stem cell assays. Moreover, there is a lack of awareness regarding stem cell assays, and as a result, there is a dearth of skilled professionals which restrains market growth. However, growing healthcare activities and the increasing demand for treatment is likely to bring stem cell assays to the forefront and opportunities in the market are plentiful.
Key Players
Prominent players included in MRFR’s report are Cell Biolabs, Inc., Thermo Fisher Scientific, Hemogenix, Merck KGaA, Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cellular Dynamics International Inc., STEMCELL Technologies Inc., and others
Market Segmentation
Market structure is determined by its various significant sections which, in the report have been segmented on the basis of product, technology, assay, application, end-user, and region. Products in the market include flow cytometer, cell imaging systems, automated cell counter, kits, and others. The kits segment has been sub-segmented and includes umbilical cord stem cells, induced pluripotent stem cell kits, mesenchymal stem cell kits, and others.
The technology used in stem cell assays include microfluidics-based cell trap technologies, microfabricated assisted technology, synthetic stem cells and others
Assays in the market include cell identification assays, cell viability & toxicity assays, cell proliferation assays, cell apoptosis assays, and others.
Applications of stem cell assays can be found in orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others.
End-users of stem cell assays include research organizations, academic institutes, biotechnology industries, academic institutes, and others.
Regional Analysis
The Americas have captured the dominant share of the global market. The presence of North America in the region has had a significant impact on the regions market share possession. The rapid adoption of advanced medical technologies and the presence of a large patient population for various chronic diseases drive the Americas' market. Moreover, the regions healthcare expenditure is rising, and there are several leading players present in the North American sub-market.
Meanwhile, growing at the fastest pace is the Asia Pacific regional market. Gradually increasing awareness regarding advanced medical biotechnology is strongly impacting growth in the region. Several emerging economies in the region have a rapidly growing biotechnology sector which fuelling market growth. Findings by the Indian Brand Equity Foundation suggest that the Indian subcontinent has 2% of the global biotechnology share. Several opportunities in the region are expected to lead to market proliferation.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The global nurse call system market is expected to grow significantly over the forecast period. It is estimated that the global nurse call system market is expected to register a CAGR ~ 9.5 % during the forecast period from 2018 to 2023. Nurse call systems are aimed at alerting the nurses in case of medical emergency situations or when patients need care. These systems are also used to track a patient particularly in assisted living or old age centers or are used to give a signal of a probable situation in case of ambulatory services.
Numerous factors such as growing geriatric population and rising complexity of hospital operations are expected to drive the growth of the market.
Moreover, favorable healthcare investments by government and the rising demand for better technological advancements boosts the growth of the market. However, stringent government regulation and the huge cost of installation may hamper the market growth during the assessment period.
Some of the industry players offer integrated equipment, in which the patient data can easily be stored and retrieved. In February 2015, Rauland Borg Corporation launched a device called AllTouch responder, which offers nurse call system market with electronic medical records. The nurse call equipment has evolved over the time owing to better patient monitoring. The staff members can directly communicate with the patients to assist them and provide required care, thereby reducing the need to visit the patient beds for minor requirements. This can eliminate fatigue and increase the workflow efficiency of the attendant.
Competitive Analysis:
Some of the major companies in the global nurse call system market include Honeywell International Inc., Austco Communication Systems Pty Ltd., Hill-Rom Services Inc., Johnson Controls., Ascom, CSINC, STANLEY Healthcare, AMETEK, Inc., West-Com Nurse Call System, Inc, Cornell Communications, Azure Healthcare, Jeron Electronic Systems Inc., BEC Integrated Solutions, LLC, Vigil Health Solutions Inc., and Systems Technologies.
Segmentation:
The nurse call system market is segmented on type, applications, technology, end users, and region.
Based on the type, the market is segregated into nurse call integrated communication systems, nurse call buttons, nurse call intercoms, nurse call mobile systems, and others.
By technology, the market is segmented into wireless systems and wired systems.
Based on the applications, the market is segmented into alarms, medical emergency, workflow management, and others.
Based on the end users, it is segmented into assisted living centers, hospitals & nursing homes, ambulatory care centers, and others. Of these, hospitals and nursing homes segment is anticipated to be the larger shareholder in the overall market share. The growth of the segment is primarily attributable to the rising number of public as well as private hospitals.
Regional Analysis:
Regionally, the nurse call system market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, the Americas is anticipated to dominate the market for nurse call system due to faster demand for newer technologies and upgradation of nurse call systems in the region. Additionally, the growing geriatric population and increasing funding for better healthcare infrastructure in the region. In addition to this, the Europe is estimated to hold the second leading position in the market owing to well-developed healthcare industry and investment for increasing number of hospitals.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the developing healthcare facilities in the developing economies and increasing aging population. According to a report published by Silver Eco in October 2017, in Japan, 27.7 people are elderly or aged.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America